Search results
The path to a better Tuberculosis vaccine runs through Montana
The Norman Transcript· 5 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
The Way We Were: 68 years ago, old TB treatment center became Naperville’s first medical center —...
Chicago Tribune· 22 hours agoBefore it became Edward Hospital 68 years ago, the medical facility on Washington Street was known...
We neglect ancient killers like tuberculosis at our peril - The Boston Globe
The Boston Globe· 2 days agoKoch revealed to his assembled colleagues that he had found the cause of tuberculosis: a germ he called Mycobacterium tuberculosis. Another notable German ...
Posts mislead on migrants spreading tuberculosis in US
AFP via Yahoo News· 4 days agoTuberculosis (TB) cases in the United States have increased every year since 2020, but posts linking...
How do you keep calm and carry on in a world full of crises?
NPR· 2 days agoLook at that pain and don't ignore it. I am someone who wasn't allowed to express themselves growing...
Indian study shows whole-genome sequencing key to detect drug-resistant TB early
Investing.com· 4 days agoTuberculosis stands as the second leading infectious disease killer globally, with over 2.95 million...
Drugs that aren’t antibiotics can also kill bacteria − new method pinpoints how
The Raw Story· 2 days agoHuman history was forever changed with the discovery of antibiotics in 1928. Infectious diseases...
Aid Group Sounds Alarm About Migrant Health Problems
Barron s Online· 21 hours agoIt decried the "political use" of the migration situation "to win votes in societies increasingly hostile to foreigners," in what is an election year in both Mexico and the United States. MSF ...
Umbrella Toxins: A Groundbreaking Class of Antimicrobials Found in Soil Bacteria
SciTechDaily· 6 hours agoResearchers have discovered toxic protein particles, shaped like umbrellas, that soil bacteria known...
Bosch, R-Biopharm to Invest €150M in PCR Tests for Vivalytic MDx Platform
GenomeWeb News· 1 day agoBosch and R-Biopharm said Thursday that they will jointly invest €150 million ($160 million) by the end of the decade into the development and marketing of new in vitro diagnostic PCR assays ...